3 Wilson disease
暂无分享,去创建一个
[1] B. Portmann,et al. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease , 1992, Hepatology.
[2] L. Farrer,et al. Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[3] S. Govindarajan,et al. Hepatocellular carcinoma in a case of Wilson's disease. , 2008, Liver.
[4] R. MacGillivray,et al. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[5] P. Vajro,et al. Penicillamine-related neurologic syndrome in a child affected by Wilson disease with hepatic presentation. , 1997, Archives of neurology.
[6] I. Sternlieb,et al. Prevention of Wilson's disease in asymptomatic patients. , 1968, The New England journal of medicine.
[7] D. Cox,et al. The Wilson disease gene: spectrum of mutations and their consequences , 1995, Nature Genetics.
[8] O. Mjølnerød,et al. Congenital connective-tissue defect probably due to D-penicillamine treatment in pregnancy. , 1971, Lancet.
[9] C. Datz,et al. Detection of the His1069Gln Mutation in Wilson Disease by Rapid Polymerase Chain Reaction , 1997, Annals of Internal Medicine.
[10] I. Sternlieb,et al. The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. , 1987, New England Journal of Medicine.
[11] T. Hoogenraad,et al. Management of Wilson's disease with zinc sulphate Experience in a series of 27 patients , 1987, Journal of the Neurological Sciences.
[12] Cox Dw. Molecular advances in Wilson disease. , 1996 .
[13] S. Virgiliis,et al. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations. , 1995, American journal of human genetics.
[14] J. Jankovic,et al. Neurologic presentation of Wilson disease without Kayser-Fleischer rings , 1996, Neurology.
[15] Burton Combes,et al. Low serum alkaline phosphatase activity in Wilson's disease , 1986, Hepatology.
[16] I. Sternlieb. Mitochondrial and fatty changes in hepatocytes of patients with Wilson's disease. , 1968, Gastroenterology.
[17] J. Rommens,et al. The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene , 1993, Nature Genetics.
[18] L. Deecke,et al. Wilson's disease , 1993, Neurology.
[19] R. Russell,et al. Use of a stable copper isotope (65Cu) in the differential diagnosis of Wilson's disease. , 1995, Clinical science.
[20] J. Walshe,et al. DIAGNOSIS AND TREATMENT OF PRESYMPTOMATIC WILSON'S DISEASE , 1988, The Lancet.
[21] R. Kliegman,et al. Pigmented corneal rings in neonates with liver disease. , 1987, The Journal of pediatrics.
[22] T. Gilliam,et al. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. , 1997, American journal of human genetics.
[23] M. Czaja,et al. Hepatocellular copper toxicity and its attenuation by zinc. , 1989, The Journal of clinical investigation.
[24] J. Walshe. TREATMENT OF WILSON'S DISEASE WITH TRIENTINE (TRIETHYLENE TETRAMINE) DIHYDROCHLORIDE , 1982, The Lancet.
[25] P. Fox,et al. Role of ceruloplasmin in cellular iron uptake. , 1998, Science.
[26] J. Walshe,et al. Chelation treatment of neurological Wilson's disease. , 1993, The Quarterly journal of medicine.
[27] D W Cox,et al. The toxic milk mouse is a murine model of Wilson disease. , 1996, Human molecular genetics.
[28] G. Hill,et al. Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens , 1987, Hepatology.
[29] J. Morita,et al. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations. , 1992, Developmental Pharmacology and Therapeutics.
[30] D. Cox,et al. Haplotypes and mutations in Wilson disease. , 1995, American journal of human genetics.
[31] A. Young,et al. Initial therapy of patients with Wilson's disease with tetrathiomolybdate. , 1991, Archives of neurology.
[32] D. Cox,et al. The Application of DNA Markers to the Diagnosis of Presymptomatic Wilson Disease , 1989 .
[33] T. Gilliam,et al. Two forms of Wilson disease protein produced by alternative splicing are localized in distinct cellular compartments. , 1997, The Biochemical journal.
[34] P. Ryan,et al. Penicillamine, its metabolism and therapeutic applications: A review , 1979, Biopharmaceutics & drug disposition.
[35] S. Packman,et al. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper–transporting ATPase , 1993, Nature Genetics.
[36] G. Brewer,et al. Treatment of Wilson's disease with zinc: XIV. Studies of the effect of zinc on lymphocyte function. , 1997, The Journal of laboratory and clinical medicine.
[37] J. Walshe. Pregnancy in Wilson's disease. , 1977, The Quarterly journal of medicine.
[38] G. Mieli-Vergani,et al. Failure of simple biochemical indexes to reliably differentiate fulminant wilson's disease from other causes of fulminant liver failure , 1992, Hepatology.
[39] P. Kuan. Cardiac Wilson's disease. , 1987, Chest.
[40] P. Hedera,et al. Treatment of Wilson Disease With Ammonium Tetrathiomolybdate: III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy , 1996 .
[41] C. Lui,et al. Neurological improvement of Wilson's disease after liver transplantation. , 1997, Transplantation proceedings.
[42] J. Rathbun,et al. Neuropsychological aspects of Wilson's disease. , 1996, The International journal of neuroscience.
[43] J. Walshe,et al. Wilson's disease: the problem of delayed diagnosis. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[44] T. Dening,et al. Wilson's disease and epilepsy. , 1988, Brain : a journal of neurology.
[45] S. Sherlock,et al. Wilson's disease, presenting as chronic active hepatitis , 1978 .
[46] A. Rötig,et al. Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis. , 1995, Gastroenterology.
[47] I. Saatci,et al. Cranial MR findings in Wilson's disease , 1997, Acta radiologica.
[48] H. Hefter,et al. Wilson disease: clinical presentation, treatment, and survival. , 1991, Annals of internal medicine.
[49] H. Popper,et al. Progress in Liver Diseases , 1962 .
[50] P. Harper,et al. REVERSIBLE PANCYTOPENIA SECONDARY TO TREATMENT WITH TETRATH10‐MOLYBDATE , 1986, British journal of haematology.
[51] S. Nakada,et al. Wilson's disease presenting as symptomatic urolithiasis: a case report and review of the literature. , 1994, The Journal of urology.
[52] G. de las Heras,et al. Wilson's disease treated with trientine during pregnancy. , 1995, Journal of pediatric gastroenterology and nutrition.
[53] R. Calne,et al. Reversal of severe neurological manifestations of Wilson's disease following orthotopic liver transplantation. , 1987, The Quarterly journal of medicine.
[54] L. Cavalli-Sforza,et al. Predictive testing for Wilson's disease using tightly linked and flanking DNA markers , 1991, Neurology.
[55] B. Neuschwander‐Tetri,et al. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. , 1994, Gastroenterology.
[56] S. Sherlock,et al. IS WILSON'S DISEASE CAUSED BY A CONTROLLER GENE MUTATION RESULTING IN PERPETUATION OF THE FETAL MODE OF COPPER METABOLISM INTO CHILDHOOD? , 1981, The Lancet.
[57] E. Cauza,et al. Screening for Wilson's disease in patients with liver diseases by serum ceruloplasmin. , 1997, Journal of hepatology.
[58] L. Wetterberg. Genetics of Neuropsychiatric Diseases , 1989 .
[59] K. Hambidge,et al. Treatment of Wilson's Disease with Triethylene Tetramine Hydrochloride (Trientine) , 1990, Journal of pediatric gastroenterology and nutrition.
[60] J. Kaplan,et al. N-terminal Domains of Human Copper-transporting Adenosine Triphosphatases (the Wilson’s and Menkes Disease Proteins) Bind Copper Selectively in Vivo and in Vitro with Stoichiometry of One Copper Per Metal-binding Repeat* , 1997, The Journal of Biological Chemistry.
[61] I. Sternlieb,et al. Pregnancy in penicillamine-treated patients with Wilson's disease. , 1975, The New England journal of medicine.
[62] A. Aisen,et al. Treatment of Wilson's disease with ammonium tetrathiomolybdate. I. Initial therapy in 17 neurologically affected patients. , 1994, Archives of neurology.
[63] J M Walshe,et al. Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients. , 1989, The Quarterly journal of medicine.
[64] Jingshi Wu,et al. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene , 1994, Nature Genetics.
[65] J. Peppercorn,et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene , 1993, Nature Genetics.
[66] E. Dickson,et al. Diagnosis of Wilson's disease presenting as fulminant hepatic failure. , 1983, Gastroenterology.
[67] G. Corazza,et al. Zinc therapy in Wilson's disease: observations in five patients. , 1990, The American journal of gastroenterology.
[68] I. Sternlieb,et al. Prognosis of Wilsonian chronic active hepatitis. , 1991, Gastroenterology.
[69] D. Pessayre,et al. Premature oxidative aging of hepatic mitochondrial DNA in Wilson's disease. , 1997, Gastroenterology.
[70] I. Koyama,et al. Low serum alkaline phosphatase activity associated with severe Wilson's disease. Is the breakdown of alkaline phosphatase molecules caused by reactive oxygen species? , 1995, Clinica chimica acta; international journal of clinical chemistry.
[71] R. Klausner,et al. Biochemical Characterization of the Wilson Disease Protein and Functional Expression in the Yeast Saccharomyces cerevisiae * , 1997, The Journal of Biological Chemistry.
[72] T. Nakajima,et al. Haplotype and mutation analysis in Japanese patients with Wilson disease. , 1997, American journal of human genetics.
[73] K. Schärer,et al. Proteinuria and other renal functions in Wilson’s disease , 1997, Pediatric Nephrology.
[74] J. Walshe. The management of pregnancy in Wilson's disease treated with trientine. , 1986, The Quarterly journal of medicine.
[75] A. Herneth,et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. , 1997, Gastroenterology.
[76] J. Sarles,et al. Successful medical treatment of severely decompensated Wilson disease. , 1996, The Journal of pediatrics.
[77] R. Sokol,et al. Abnormal hepatic mitochondrial respiration and cytochrome C oxidase activity in rats with long-term copper overload. , 1993, Gastroenterology.
[78] A. Algra,et al. Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. , 1996, Radiology.
[79] C. Lang,et al. Fatal deterioration of Wilson's disease after institution of oral zinc therapy. , 1993, Archives of neurology.
[80] W. Stremmel,et al. Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. , 1994, Journal of hepatology.
[81] J. Juyn,et al. H714Q mutation in Wilson disease is associated with late, neurological presentation. , 1995, Journal of medical genetics.
[82] G. Brewer,et al. Treatment of Wilson's disease with zinc. , 1999, The Journal of laboratory and clinical medicine.
[83] I. Sternlieb,et al. Liver transplantation for Wilson's disease: Indications and outcome , 1994, Hepatology.
[84] D. Cox,et al. Expression, Purification, and Metal Binding Properties of the N-terminal Domain from the Wilson Disease Putative Copper-transporting ATPase (ATP7B)* , 1997, The Journal of Biological Chemistry.
[85] Caballero Et,et al. [Wilson's disease]. , 1965 .
[86] B. Esmaeli,et al. Regression of Kayser-Fleischer rings during oral zinc therapy: correlation with systemic manifestations of Wilson's disease. , 1996, Cornea.
[87] I. Sternlieb. Fraternal concordance of types of abnormal hepatocellular mitochondria in Wilson's disease , 1992, Hepatology.
[88] J. Walshe,et al. Zinc-induced deterioration in Wilson's disease aborted by treatment with penicillamine, dimercaprol, and a novel zero copper diet. , 1995, Archives of neurology.